COVID-19

News

Celltrion trials infliximab biosimilar in recovering COVID-1...

South Korea’s Celltrion Healthcare has begun a UK trial of its infliximab biosimilar to see if the drug can accelerate recovery from symptoms of COVID-19.

News

Regeneron begins trials of COVID-19 antibody cocktail

Regeneron has said it has begun clinical trials of its antibody cocktail therapy for COVID-19, as pharma companies continue their search for treatments as the pandemic continues to cause ha

News

J&J brings forward start of COVID-19 vaccine trial to next m...

Johnson & Johnson has announced it has brought forward the start of its COVID-19 vaccine by around two months to mid-July.

Views & Analysis

Digital health predicted as the new normal in COVID aftermat...

There are few countries left unaffected by COVID-19 and solutions can’t seem to arrive soon enough.

News

Brexit drug stock piles 'used up' during coronavirus pandemi...

The pharma industry has warned that the UK’s stockpiles of medical supplies intended to cover disruption caused by Brexit have been “used up entirely” by the effort against the coronavirus,

News

Gilead files remdesivir for EU approval, with a verdict poss...

The EMA has said it will fast-track the review of Gilead Sciences’ remdesivir as a treatment for COVID-19, after the US biopharma submitted its marketing application for the dr

Celltrion trials infliximab biosimilar in recovering COVID-1...

Regeneron begins trials of COVID-19 antibody cocktail

J&J brings forward start of COVID-19 vaccine trial to next m...

Digital health predicted as the new normal in COVID aftermat...

Brexit drug stock piles 'used up' during coronavirus pandemi...

Gilead files remdesivir for EU approval, with a verdict poss...

CEPI steps in to fund Moderna's pandemic flu jab

How to meet your physicians where they are online

COVID-19

Editor's Picks